A pathomorphological complete response to neoadjuvant chemotherapy with carboplatin plus paclitaxel in stage IIIA central squamous cell carcinoma of the lung
- 20 February 2026
- journal article
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (1)
Abstract
The article presents a rare clinical case of examination and treatment of a patient with stage IIIA lung squamous cell carcinoma. After neoadjuvant chemotherapy using the standard regimen of paclitaxel-carboplatin (6 injections), a complete pathomorphological response was achieved based on the results of histological and immunohistochemical examination of the postoperative material. During 12 months of follow-up, no recurrences were observed. In light of the results obtained, the issue of the potential benefits of omitting the surgical treatment stage after achieving a complete pathomorphological response to neoadjuvant chemotherapy is raised. Further prospective studies are needed to confirm these conclusions.Keywords
This publication has 17 references indexed in Scilit:
- Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trialThe Lancet Oncology, 2024
- Neoadjuvant Chemoimmunotherapy for NSCLCJAMA Oncology, 2024
- Complete pathologic response to short-course neoadjuvant alectinib in mediastinal node positive (N2) ALK rearranged lung cancerLung Cancer, 2022
- Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung CancerNew England Journal of Medicine, 2022
- Correction to: “Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”Annals of Oncology, 2019
- Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2017
- Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant dataThe Lancet, 2014
- Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control TrialsJournal of Thoracic Oncology, 2010
- Role of preoperative chemotherapy for non-small-cell lung cancer: A meta-analysisLung Cancer, 2006
- A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung CancerNew England Journal of Medicine, 1994